David Adams focuses on food and drug law, and has led the expansion of Venable’s FDA Group.

He concentrates on Food and Drug Administration (FDA) approval and marketing of drugs, devices, and biologicals, as well as regulation of food and dietary supplements.

Mr. Adams also represents clients before the Federal Trade Commission (FTC), Drug Enforcement administration (DEA) and other agencies, the courts, Congress and the National Advertising Division of the Better Business Bureaus (NAD). His work encompasses:

• regulatory counseling
• lobbying
• private business negotiation
• litigation
• advocacy before federal agencies and NAD 

Mr. Adams is recognized in The Best Lawyers in America for FDA Law. Before joining Venable, he held senior positions at the FDA.

Representative Clients

Mr. Adams represents manufacturers and distributors of prescription and over-the-counter medications, medical devices, cutting-edge biotechnology products, foods, dietary supplements and cosmetics.

He also represents trade associations for FDA-regulated companies and medical and professional societies.

Significant Matters

• Mr. Adams has provided counsel on numerous drug, device, biologic and food issues and appeals before the FDA.
• He has successfully represented companies in complex litigation involving FDA’s approval processes and other regulatory issues. 
• Mr. Adams has represented clients in FTC, criminal and Congressional investigations.
• He has successfully lobbied Congress on important food and drug legislation.

Activities

Mr. Adams teaches Food and Drug Law at the George Washington University Law School.

He is an editor of Food and Drug Law and Regulation, a food and drug law reference text.

Mr. Adams has served as chair of the Food and Drug Law Committee of the ABA Section of Business Law, as well as chair of the editorial board for the Food and Drug Law Journal.